Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check6 days agoChange DetectedAdded a new revision tag, Revision: v3.6.4, and removed certain related topics and the older Revision: v3.6.3 from the page, reflecting a minor update to the site’s versioning and navigation metadata.SummaryDifference0.2%

- Check13 days agoChange DetectedAdded related topics for Cystic fibrosis and MedlinePlus Genetics to the page, connecting users to genetics resources. These are navigational resources that help users explore genetics context around the study.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.6.3 is now shown on the page. References to Cystic fibrosis, related topics, MedlinePlus Genetics, and the previous revision label Revision: v3.6.2 were removed.SummaryDifference0.2%

- Check35 days agoChange DetectedAdds 'Cystic fibrosis' as a listed condition/topic and introduces a related topics entry for MedlinePlus Genetics. The page revision tag is updated to v3.6.2, replacing v3.6.0.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now shows that recruitment has ceased for participants. New help and navigation sections, including How to Read a Study Record, Common Questions, and How to Join a Study, were added.SummaryDifference0.5%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing v3.5.4, indicating a new version of the page rendering. This is a backend update without changes to study information.SummaryDifference0.1%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.